Xenon Pharmaceuticals Inc

XP0

Company Profile

  • Business description

    Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

  • Contact

    200-3650 Gilmore Way
    BurnabyBCV5G 4W8
    CAN

    T: +1 604 484-3300

    E: [email protected]

    https://www.xenon-pharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    327

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,774.8086.801.00%
CAC 407,615.9978.421.04%
DAX 4023,644.21375.201.61%
Dow JONES (US)43,011.75429.971.01%
FTSE 1008,758.990.950.01%
HKSE24,177.07487.942.06%
NASDAQ19,905.30274.331.40%
Nikkei 22538,790.56436.471.14%
NZX 50 Index12,467.4865.17-0.52%
S&P 5006,084.2959.120.98%
S&P/ASX 2008,555.5080.600.95%
SSE Composite Index3,420.5738.981.15%

Market Movers